Poehling Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
SMDAM
CRM
FWCM
Poehling Capital Management's AMGN Position: Q2 2026 in Review
Poehling Capital Management opened a new position in Amgen (AMGN) in Q2 2026: 564 shares worth $204K. The stake represents 0.04% of the portfolio and ranks #160 among its holdings. This is a return to the name: Poehling Capital Management previously reported a position in AMGN as recently as Q4 2024.
Poehling Capital Management first reported a position in AMGN in Q4 2017 and has held it in 24 quarters since. The position peaked at $3.83M in Q1 2022. 911 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Poehling Capital Management held 564 shares of Amgen worth $204K as of Q2 2026.
- Amgen was a new Poehling Capital Management position in Q2 2026.
- Amgen made up 0.04% of Poehling Capital Management's portfolio in Q2 2026, its #160 holding.
- Poehling Capital Management first reported a position in Amgen in Q4 2017 and has held it in 24 quarters since.
- Poehling Capital Management's Amgen position peaked at $3.83M in Q1 2022.
- 911 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Poehling Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.